anti-TGF beta mAb (Sanofi-Genzyme/Ludwig Maximilians Universitaet Muenchen)

N/A

Report date: 2025/03/14 16:39:11

Base Information

Drug Nameanti-TGF beta mAb (Sanofi-Genzyme/Ludwig Maximilians Universitaet Muenchen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesLudwig-Maximilians-Universität MünchenGenzyme Corp
Inactive CompaniesN/A
Active IndicationsKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A